Literature DB >> 14618366

Contrast-enhanced MR angiography vs intra-arterial digital subtraction angiography for carotid imaging: activity-based cost analysis.

Jean Marie U-King-Im1, William Hollingworth, Rikin A Trivedi, Justin J Cross, Nicholas J Higgins, Martin J Graves, Peter J Kirkpatrick, Nagui M Antoun, Jonathan H Gillard.   

Abstract

The aim of this study was to compare the costs of performing contrast-enhanced MR angiography (CE MRA) with intra-arterial digital subtraction angiography (DSA) for the evaluation of carotid atherosclerotic disease. Activity-based cost analysis was used to identify the costs of performing each procedure. The variable direct costs of performing CE MRA and DSA were determined in 20 patients by using detailed time and motion studies. All personnel directly involved in the cases were tracked to the nearest minute and all consumable items used were recorded. Moreover, procedure times were prospectively recorded for an additional 80 patients who underwent both DSA and CE MRA. The variable direct costs of bed usage in the angiography day-case unit, all direct fixed costs as well as indirect costs were assessed from hospital and departmental accounting records. Total costs for each procedure were calculated and compared using Wilcoxon signed-rank sum test. Mean aggregate costs were Euro 721 for DSA and Euro 306 for CE MRA, resulting in potential savings of Euro 415 per patient (p<0.0001). On average, a DSA procedure thus cost approximately 2.4 (95% confidence intervals: 2.2-2.6) times more than CE MRA to our medical institution. Sensitivity analyses confirmed the robustness of our conclusions across wide ranges of plausible values for various parameters. Assuming equal diagnostic performance, institutions may have substantial cost savings if CE MRA is used instead of DSA for carotid imaging.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618366     DOI: 10.1007/s00330-003-2127-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

1.  Activity-based cost analysis: a method of analyzing the financial and operating performance of academic radiology departments.

Authors:  M D Cohen; D R Hawes; G D Hutchins; W D McPhee; M B LaMasters; R P Fallon
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

2.  Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography.

Authors:  Luca Remonda; Pascal Senn; Alain Barth; Marcel Arnold; Karl-Olof Lövblad; Gerhard Schroth
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

Review 3.  The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review.

Authors:  E Berry; S Kelly; M E Westwood; L M Davies; M J Gough; J M Bamford; J F M Meaney; C M Airey; J Cullingworth; M Barbieri; A Jackson; M A Smith
Journal:  Health Technol Assess       Date:  2002       Impact factor: 4.014

4.  Contrast-enhanced three-dimensional MR angiography of neck vessels: does dephasing effect alter diagnostic accuracy?

Authors:  M Cosottini; R Calabrese; M Puglioli; V Zampa; C Michelassi; S Ortori; L Murri; C Bartolozzi
Journal:  Eur Radiol       Date:  2002-07-25       Impact factor: 5.315

5.  Prospective evaluation of carotid artery stenosis: elliptic centric contrast-enhanced MR angiography and spiral CT angiography compared with digital subtraction angiography.

Authors:  Juan Alvarez-Linera; Julián Benito-León; José Escribano; Jorge Campollo; Ricardo Gesto
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

6.  Imaging of carotid artery stenosis: clinical efficacy and cost-effectiveness.

Authors:  R Vanninen; H Manninen; S Soimakallio
Journal:  AJNR Am J Neuroradiol       Date:  1995-10       Impact factor: 3.825

7.  Preoperative testing before carotid endarterectomy: a survey of vascular surgeons' attitudes.

Authors:  D L Dawson; C A Roseberry; R M Fujitani
Journal:  Ann Vasc Surg       Date:  1997-05       Impact factor: 1.466

8.  Contrast-enhanced three-dimensional magnetic resonance angiography of atherosclerotic internal carotid stenosis as the noninvasive imaging modality in revascularization decision making.

Authors:  Mirco Cosottini; Alessandro Pingitore; Michele Puglioli; Maria Chiara Michelassi; Giancarlo Lupi; Arturo Abbruzzese; Rosa Calabrese; Massimo Lombardi; Giuliano Parenti; Carlo Bartolozzi
Journal:  Stroke       Date:  2003-02-20       Impact factor: 7.914

9.  A comparison of work-sampling and time-and-motion techniques for studies in health services research.

Authors:  S A Finkler; J R Knickman; G Hendrickson; M Lipkin; W G Thompson
Journal:  Health Serv Res       Date:  1993-12       Impact factor: 3.402

Review 10.  Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature.

Authors:  Robert A Willinsky; Steve M Taylor; Karel TerBrugge; Richard I Farb; George Tomlinson; Walter Montanera
Journal:  Radiology       Date:  2003-03-13       Impact factor: 11.105

View more
  4 in total

1.  [The significance of MR angiography for the diagnosis of carotid stenoses].

Authors:  H J Michaely; K A Herrmann; H Kramer; G Laub; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2004-10       Impact factor: 0.635

Review 2.  Ischemic stroke: carotid and vertebral artery disease.

Authors:  P Vilela; A Goulão
Journal:  Eur Radiol       Date:  2005-01-19       Impact factor: 5.315

3.  Contrast-enhanced time-resolved 3-D MRA: applications in neurosurgery and interventional neuroradiology.

Authors:  Peter C Reinacher; Paul Stracke; Marcus H T Reinges; Franz J Hans; Timo Krings
Journal:  Neuroradiology       Date:  2007-07       Impact factor: 2.804

4.  Study of Vertebral Artery Dissection by Ultrasound Superb Microvascular Imaging Based on Deep Neural Network Model.

Authors:  Yanjuan Wang; Huajie Jiao; Huihui Peng; Jinfang Liu; Liyuan Ma; Jianjun Wang
Journal:  J Healthc Eng       Date:  2022-02-26       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.